Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

  1. Ning Yang
  2. Xuebo Lu
  3. Yanan Jiang
  4. Lili Zhao
  5. Donghao Wang
  6. Yaxing Wei
  7. Yin Yu
  8. Myoung Ok Kim
  9. Kyle Vaughn Laster
  10. Xin Li
  11. Baoyin Yuan
  12. Zigang Dong  Is a corresponding author
  13. Kangdong Liu  Is a corresponding author
  1. Zhengzhou University, China
  2. Kyungpook National University, Republic of Korea
  3. China-US Hormel Cancer Institute, China
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/73953/elife-73953-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ning Yang
  2. Xuebo Lu
  3. Yanan Jiang
  4. Lili Zhao
  5. Donghao Wang
  6. Yaxing Wei
  7. Yin Yu
  8. Myoung Ok Kim
  9. Kyle Vaughn Laster
  10. Xin Li
  11. Baoyin Yuan
  12. Zigang Dong
  13. Kangdong Liu
(2022)
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
eLife 11:e73953.
https://doi.org/10.7554/eLife.73953